XML 26 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS
¥ in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2022
CNY (¥)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
CNY (¥)
Dec. 31, 2020
CNY (¥)
Cash flows from operating activities:        
Net loss ¥ (7,507,653) $ (1,088,507) ¥ (6,808,739) ¥ (3,054,017)
Adjustments to reconcile net loss to net cash provided by/(used in) operating activities:        
Depreciation of property and equipment 755,500 109,530 538,601 326,512
Amortization of intangible assets 2,581,300 374,257 1,903,226 1,395,129
Amortization of right-of-use assets 229,295 33,245 161,873 96,235
Amortization of debt issuance costs 48,167 6,984 25,234 19,291
Share-based compensation expenses 1,040,683 150,885 999,817 385,898
Allowance for doubtful accounts 130,549 18,928 189,165 99,165
Inventory provision 191,088 27,705 24,454 6,218
Deferred income taxes (36,495) (5,291) (21,492) (13,466)
Unrealized exchange (gains)/losses 2,277 330 (6,592) (3,018)
Unrealized fair value changes of investments 251,383 36,447 200,274 (50,641)
Loss on disposal of property and equipment 748 108 611  
Termination expenses of certain game projects 525,762 76,228    
Gain from disposal of subsidiaries and long-term investments (178,378) (25,862) (4,413)  
Loss from equity method investments 211,600 30,682 37,179 50,531
Revaluation of previously held equity interests (152,153) (22,060) 31,462  
Impairments of long-term investments 465,600 67,512 91,493 8,000
Gain of convertible senior notes repurchase (1,318,594) (191,178)    
Changes in operating assets and liabilities:        
Accounts receivable (59,866) (8,680) (429,460) (417,237)
Amount due from related parties (74,117) (10,746) 8,792 17,015
Prepayments and other assets (556,214) (80,644) (1,747,744) (610,592)
Other long-term assets (444,326) (64,421) (138,396) (245,224)
Accounts payable 46,862 6,794 1,056,847 816,103
Salary and welfare payable 396,113 57,431 254,213 374,442
Taxes payable 130,684 18,947 77,365 54,381
Deferred revenue 173,935 25,218 494,551 734,786
Accrued liabilities and other payables (1,026,319) (148,803) 319,702 651,651
Amount due to related parties (21,210) (3,075)    
Other long-term liabilities 282,367 40,939 94,969 111,941
Net cash provided by/(used in) operating activities (3,911,400) (567,097) (2,647,008) 753,103
Cash flows from investing activities:        
Purchase of property and equipment (760,427) (110,252) (965,410) (602,122)
Purchase of intangible assets (1,977,897) (286,768) (2,721,799) (1,636,877)
Purchase of short-term investments (70,578,711) (10,232,951) (71,748,847) (26,731,176)
Maturities of short-term investments 81,698,532 11,845,174 60,524,888 24,921,538
Cash consideration paid for purchase of subsidiaries, net of cash acquired (1,179,764) (171,050) (521,984) (498,854)
Cash paid for long-term investments including loans (1,466,311) (212,595) (6,716,491) (1,261,161)
Repayment of loans from investees 596,766 86,523 539,225 3,500
Cash received from disposal/return of long-term assets 612,214 88,762 74,604 135,254
Placements of time deposits (10,245,026) (1,485,389) (10,697,444) (10,907,296)
Maturities of time deposits 13,909,967 2,016,756 7,655,147 7,670,373
Impact to cash resulting from deconsolidation of subsidiaries (125) (18)    
Net cash (used in)/provided by investing activities 10,609,218 1,538,192 (24,578,111) (8,906,821)
Cash flows from financing activities:        
Proceeds of short-term loan 1,701,532 246,699 1,332,597 200,000
Repayment of short-term loan (1,450,627) (210,321) (214,882) (100,000)
Repurchase of noncontrolling interests (56,741) (8,227) (104,696) (280,271)
Capital injections from noncontrolling interests     2,187 103,450
Proceeds from exercise of employees' share options 4 1 3 3
Proceeds from issuance of ordinary shares, net of issuance costs of US$563, HKD337,143 and nil, respectively     19,288,423 2,817,458
Repurchase of convertible senior notes (4,201,506) (609,161)    
Repurchase of shares (347,581) (50,395)    
Proceeds from issuance of convertible senior notes, net of issuance costs of US$13,857, US$23,402 and nil, respectively     10,085,520 5,594,779
Net cash provided by/(used in) financing activities (4,354,919) (631,404) 30,389,152 8,335,419
Effect of exchange rate changes on cash and cash equivalents and restricted cash held in foreign currencies 321,350 46,593 (319,034) (466,252)
Net (decrease)/increase in cash and cash equivalents and restricted cash 2,664,279 386,284 2,844,999 (284,551)
Cash and cash equivalents and restricted cash at beginning of the year 7,523,108 1,090,748 4,678,109 4,962,660
Cash and cash equivalents and restricted cash at end of the year 10,187,387 1,477,032 7,523,108 4,678,109
Cash and cash equivalents and restricted cash at end of the year 10,172,584 1,474,886 7,523,108 4,678,109
Restricted cash at end of the year 14,803 2,146    
Supplemental disclosures of cash flows information:        
Cash paid for income taxes, net of tax refund 80,591 11,685 73,717 54,022
Cash paid for interest expense 200,172 29,022 116,226 86,167
Supplemental schedule of non-cash investing and financing activities:        
Accretion to redeemable noncontrolling interests       5,964
Property and equipment purchases financed by accounts payable 46,066 6,679 183,203 25,797
Acquisitions and investments financed by payables 202,018 29,290 731,503 125,363
Intangible assets purchases financed by payables 824,929 119,603 830,596 746,404
Issuance of ordinary shares in the business combination, purchase of noncontrolling interests and investment addition   1,207,980 ¥ 889,957
Issuance of ordinary shares in connection with debt conversion ¥ 96 $ 14 ¥ 449,914